Mikkel Wiberg

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

A. Kjær, P. Rossing, S. Inzucchi, 2021, Journal of the American Heart Association.

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)

A. Kjær, P. Rossing, S. Inzucchi, 2019, BMJ Open.